IONIS PHARMACEUTICALS INC
Q4 2024 13F Holders
CUSIP
462222AF7
Type
Debt
Class
NOTE 1.750% 6/1
Num filings
48
Total reported value, excl. options
$499 M
Compare 2024 Q4 to
2025 Q1
2024 Q3
2024 Q2
Manager
Report Date
Value ($000)
Principal
Option Type